Xeris Biopharma Holdings
XERS
XERS
225 hedge funds and large institutions have $791M invested in Xeris Biopharma Holdings in 2025 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 79 increasing their positions, 76 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more capital invested
Capital invested by funds: $789M → $791M (+$2.84M)
2% less funds holding
Funds holding: 230 → 225 (-5)
10% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 40
Holders
225
Holding in Top 10
3
Calls
$4.79M
Puts
$433K
Top Buyers
| 1 | +$13.7M | |
| 2 | +$13.4M | |
| 3 | +$10.7M | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$6.87M |
| 5 |
BlackRock
New York
|
+$5.6M |
Top Sellers
| 1 | -$9.29M | |
| 2 | -$7.9M | |
| 3 | -$6.9M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$6.42M |
| 5 |
Jane Street
New York
|
-$5.79M |
